🇺🇸 FDA
Patent

US 7279466

Synthesis of combretastatin A-4 prodrugs and trans-isomers thereof

granted A61KA61K31/661A61P

Quick answer

US patent 7279466 (Synthesis of combretastatin A-4 prodrugs and trans-isomers thereof) held by THE ARIZONA BOARD OF REGENTS expires Mon Oct 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE ARIZONA BOARD OF REGENTS
Grant date
Tue Oct 09 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 04 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/661, A61P, A61P31/04, A61P31/10